| Brenna Brown, SLP | |
|
815 Nw 9th St Ste 180, Corvallis, OR 97330-6173 | |
| (541) 768-5157 | |
| Not Available |
| Full Name | Brenna Brown |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 815 Nw 9th St Ste 180, Corvallis, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982975801 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 013369 (Oregon) | Primary |
| Provider Name | Good Samaritan Hospital Corvallis |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
Health insurance that pays the full cost of smoking-cessation treatments can increase quit rates, compared to benefit plans that pick up only part of the tab or that offer no cessation benefits at all, according to a new review of studies.
"Top World Health Organization officials and Islamic leaders will meet in Egypt next week in an effort to stop attacks on polio workers, which are hampering the eradication of the virus in some countries with large Muslim populations," Reuters reports, noting, "Gunmen in Pakistan and Nigeria have killed more than 20 health workers in the past three months in a series of attacks linked to a backlash against the immunization program against the crippling virus."
California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.
MicroBiome TherapeuticsTM LLC, today announced completion of a $1.3 million bridge financing. It is intended to support completion of the company's two ongoing clinical studies and preparations for further clinical trials of lead product NM504, a microbiome modulator in development for type 2 diabetes and prediabetes. The bridge financing was led by current investor BVM Capital, who was joined in the round by other existing MBT investors.
Stealth Peptides Incorporated, a privately held biopharmaceutical company developing innovative therapies for cardiovascular disease and its complications, announced today that the first patient was enrolled in its multinational Phase II clinical study with Bendavia focused on ischemia reperfusion and microvascular injuries for patients experiencing acute ST-segment elevation myocardial infarction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brenna Brown, SLP Po Box 1189, Corvallis, OR 97339-1189 Ph: () - | Brenna Brown, SLP 815 Nw 9th St Ste 180, Corvallis, OR 97330-6173 Ph: (541) 768-5157 |
News Archive
Health insurance that pays the full cost of smoking-cessation treatments can increase quit rates, compared to benefit plans that pick up only part of the tab or that offer no cessation benefits at all, according to a new review of studies.
"Top World Health Organization officials and Islamic leaders will meet in Egypt next week in an effort to stop attacks on polio workers, which are hampering the eradication of the virus in some countries with large Muslim populations," Reuters reports, noting, "Gunmen in Pakistan and Nigeria have killed more than 20 health workers in the past three months in a series of attacks linked to a backlash against the immunization program against the crippling virus."
California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.
MicroBiome TherapeuticsTM LLC, today announced completion of a $1.3 million bridge financing. It is intended to support completion of the company's two ongoing clinical studies and preparations for further clinical trials of lead product NM504, a microbiome modulator in development for type 2 diabetes and prediabetes. The bridge financing was led by current investor BVM Capital, who was joined in the round by other existing MBT investors.
Stealth Peptides Incorporated, a privately held biopharmaceutical company developing innovative therapies for cardiovascular disease and its complications, announced today that the first patient was enrolled in its multinational Phase II clinical study with Bendavia focused on ischemia reperfusion and microvascular injuries for patients experiencing acute ST-segment elevation myocardial infarction.
› Verified 5 days ago
Julie Balderston, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 875 Nw Grant Ave, Corvallis, OR 97330 Phone: 541-207-7674 | |
Mrs. Kimberly Jo Magers, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3580 Nw Samaritan Dr, Physical Rehab, Corvallis, OR 97330 Phone: 541-768-5157 | |
Amy Dawn Peters, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 580 Nw Oak Ave, Corvallis, OR 97330 Phone: 541-758-6849 | |
Melinda B Croft, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4515 Sw Country Club Dr, Corvallis, OR 97333 Phone: 541-757-8068 Fax: 541-758-1030 | |
Bruce Bowlby, M.S., CCC-LSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2750 Nw Harrison Blvd, Corvallis, OR 97330 Phone: 154-160-2101 | |
Elena J Kingston, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1636 Sw Brooklane Dr, Corvallis, OR 97333 Phone: 831-239-9995 | |
Ivona M Bowman, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 815 Nw 9th St Ste 180, Corvallis, OR 97330 Phone: 541-768-5157 Fax: 541-768-9901 |